Moderna
MRNA
$43.31
Share price
-2.61%
Change (1 day)
-68.62%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Net assets
Net assets on the balance sheet as of December 2024 : S$14.54 Billion
According to Moderna
's latest financial reports the company has S$14.54 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Moderna - Net assets on balance sheet (from 2017 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $S$14.81 B | -19.02% |
| 2023-12-31 | $S$18.29 B | -28.63% |
| 2022-12-31 | $S$25.63 B | 34.06% |
| 2021-12-31 | $S$19.12 B | 464.42% |
| 2020-12-31 | $S$3.38 B | 113.91% |
| 2019-12-31 | $S$1.58 B | -24.24% |
| 2018-12-31 | $S$2.09 B | 149.96% |
| 2017-12-31 | $S$0.83 B | -31.36% |
| 2016-12-31 | $S$1.21 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | S$0.11 B | -99.20% | 🇺🇸 USA |
 | S$61.89 B | 325.39% | 🇺🇸 USA |
 | -S$48.58 Million | -100.33% | 🇺🇸 USA |
 | S$89.54 M | -99.38% | 🇺🇸 USA |
 | S$58.89 B | 304.79% | 🇨🇭 Switzerland |
 | S$74.84 M | -99.49% | 🇺🇸 USA |
 | S$95.41 B | 555.81% | 🇺🇸 USA |